AMBS >>NITRUZZZ BOUNCER// Appoints Russell Miller as Director of Investor Relations
Amarantus BioScience Holdings, Inc. (OTCQB: AMBS), a biotechnology company discovering and developing treatments and diagnostics for diseases associated with the neurodegeneration and apoptosis, today announced it has appointed Russell Miller as Director of Investor Relations.
Mr. Miller previously served as Director of Investor Relations for US Data Works and for Force Protection, Inc. He has assisted in raising capital for companies both public and private, including real estate financing, development, and joint ventures for over 20 years. He has successfully participated in private placements, mezzanine financing, joint ventures, mergers and acquisitions, reverse mergers, national exchange up-listings and acquisitions for companies on the OTC, AMEX, and NASDAQ. As a consultant Mr. Miller has assisted a multitude of companies by developing their strategic plans for growth, liquidity, and return on equity by facilitating relationships with investment bankers, government relations officers, financiers, the media, and marketing and public relation firms. He has a broad range of worldwide contacts throughout the investment banking community, which include a large number of accredited investors and investment institutions.
About Amarantus
Amarantus is a development-stage biotechnology company founded in January 2008. The Company has a focus on developing certain biologics surrounding the intellectual property and proprietary technologies it owns to treat and/or diagnose Parkinson's disease, Traumatic Brain Injury, Ischemic Heart Disease and other human diseases. The Company owns the intellectual property rights to a therapeutic protein known as Mesencephalic-Astrocyte-derived Neurotrophic Factor ("MANF") and is developing MANF-based products as treatments for brain disorders. The Company also is a Founding Member of the Coalition for Concussion Treatment (#C4CT), a movement initiated in collaboration with Brewer Sports International seeking to raise awareness of new treatments in development for concussions and nervous-system disorders. The Company also owns intellectual property and licenses for the diagnosis of Parkinson's disease and Alzheimer's disease. For further information please visit www.Amarantus.com.
Forward Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about the possible progress of the MANF technology in treating Parkinson’s disease, as well as statements about expectations, plans and prospects of the development of Amarantus' diagnostic product candidates for Parkinson’s and Alzheimer’s disease. These forward-looking statements are subject to a number of risks, uncertainties and assumptions, including the risks associated with development of therapeutic drug candidates, as well as the risks, uncertainties and assumptions relating to the development of Amarantus' new product candidates, including those identified under "Risk Factors" in Amarantus' most recently filed Annual Report on Form 10-K and Quarterly Report on Form 10-Q and in other filings Amarantus periodically makes with the SEC. Actual results may differ materially from those contemplated by these forward-looking statements Amarantus does not undertake to update any of these forward-looking statements to reflect a change in its views or events or circumstances that occur after the date of this presentation.
Contacts:
Media Contact
LHA
Don Markley, Senior Vice President
310-691-7100
dmarkley@lhai.com
and
Investor Relations
Amarantus Bioscience Holdings, Inc.
Russell Miller, Director of Investor Relations
408-737-2734 x 109
ir@amarantus.com
Source: Amarantus BioScience Holdings, Inc.
AMBS NITRUZZZ BOUNCER// Appoints Russell Miller as Director
Top 10 Most Recent News Articles
James Scott Farrin Secures 12th 'Best Law Firms' Honor
Durham's Pride in Legal Excellence Just like ol' reliable clockwork, James Scott Farrin has clinched another honor that makes the legal landscape take note. This Durham-based law office, a heavyweight in the injury claims scene, isn't just shuffling papers; they're racking up accolades on the list of 'Best Law Firms' for the 12th year running. Now, that's no small feat....
Continue Reading
Warehouse Strike Over Pensions Jolts AGNE Operations
AGNE Feels Heat as Teamsters Strike Over Pensions Damn near thought we'd seen it all, but here we are, bearings rattled by yet another strike at a time when disruption seems to be the tune of the day. Over 255 members of Teamsters Local 633 have locked horns with Associated Grocers Northeast (AGNE) in Pembroke, New Hampshire. It's not about nickel-and-diming over a pay...
Continue Reading
Intensity Therapeutics: Q3 Results Show Steady Progress
Patient Enrollment Back on Track Today feels like we're talking about a company that's finally shaking off the cobwebs—Intensity Therapeutics is back in action with their cancer trials. After hitting the brakes back in March 2025 thanks to a cash crunch, it looks like Intensity is revving up once more, thanks to some better financial footing. They've got their Phase 3...
Continue Reading
Ensign Group Lawsuit: A Wake-Up Call for Investors
The Lowdown on Ensign's Recent Troubles Alright, folks, here's the scoop that might have you reaching for the Maalox. If you've put your chips on The Ensign Group, Inc. (NASDAQ: ENSG), you might want to keep your eyes peeled. Schall, Brown & Schwartz LLP—or SBS, as the pros call 'em—is ringing the alarm bells with a securities fraud suit that's got the potential to...
Continue Reading
Rice Sets Course in Houston’s Thriving Innovation Hub
Houston's Innovation Scene Expands The ground's barely settled and already Rice University is shaking up the scene in Houston’s Ion District with the Arc. At nearly 200,000 square feet, this powerhouse is set to bridge the gap between research, industry, and entrepreneurs, pushing ideas from discovery to reality. A Groundbreaking Investment For anyone with half an idea...
Continue Reading
Hello Group Gears Up for Q3 Earnings Release
Anticipation Builds for Hello Group's Q3 Results Time flies when you're watching stocks, and believe me, December's about to get red hot for Hello Group Inc. (NASDAQ: MOMO). With their unaudited financial results for the third quarter of 2026 hitting the wire before the U.S. markets open on December 7, there's enough speculation cooking to rival a Thanksgiving feast....
Continue Reading
Workday: Dominating Cloud ERP with AI Prowess in 2026
Workday: A Force in the Cloud ERP Arena Right on! Workday's making waves again in the world of Cloud ERP. In a move that seems to defy the competition, they've locked down their spot as a Leader in the 2026 Gartner Magic Quadrant for Cloud ERP for Service-Centric Enterprises for the fifth year running. Consistency isn’t a coincidence here, folks—this is pure strategy!...
Continue Reading
Truelink's Strategic Expansion: GES Acquires CSG Creative
Truelink's Big Move in Creative Marketing I don't throw around the word 'synergy' lightly, but this Truelink Capital move has me grudgingly utter it. Picture this: GES, a big dog in event marketing, just grabbed CSG Creative, a firm with its teeth sunk deep into association and event organizer marketing. It sounds like the kind of match you only find lurking in the fancy...
Continue Reading
Coastal Financial Faces Class Action Suit Over Securities
Securities Law Tangles: Coastal Financial Hits a Snag There's no dodging it—Coastal Financial Corporation's dogged by a class action lawsuit, and investors need to sit up and take notice. This kind of legal fracas can hit the stock price like a brick through a window, especially when alleged securities law violations crop up. DJS Law Group's got the reins on this one,...
Continue Reading
Class Action Targets Extremist Groups, Interference
Legal Spar on the Horizon: Class Action Commences The legal world now sees a fresh duel as Impresa Legal Group rolls up its sleeves and files a class action lawsuit against certain extremist groups and foreign-funded entities. At the heart of this legal action are accusations that these outfits have orchestrated a campaign to intimidate data center workers while meddling...
Continue ReadingTop 5 Most Recently Viewed Articles
Valortiva Launches Octa A1: A Symphony of Sound and Style
Experience the Sound Revolution with Valortiva In a world where music and quality play pivotal roles in shaping our experiences, Valortiva emerges as a beacon of innovation in audio technology. Founded by three passionate friends—Howard, Alex, and Annie—Valortiva encapsulates their shared belief that sound is not merely something to hear; it’s an element of our...
Continue Reading
Nexans Unveils Strategic Organizational Changes for Growth
Nexans Restructures for Strategic Growth and Innovation Nexans is making significant changes to its organizational structure to enhance its business operations and drive future growth. This initiative is led by Chief Executive Officer Christopher Guérin and aims to align with the company's aspirations for profitable expansion. A New Era of Leadership The new...
Continue Reading
Fosun Pharma's Licensing Partnership for Innovative XH-S004
Fosun Pharma Secures Global Licensing for XH-S004 Fosun Pharma recently made headlines with the announcement of a significant licensing agreement for its innovative drug, XH-S004. This agreement, spanning several territories, highlights the company's growth in the global pharmaceutical arena and its commitment to delivering groundbreaking therapies. The collaboration will...
Continue Reading
Teamsters Local 665 Expands Membership at Airport Services
Teamsters Local 665 Welcomes New Members from Airport Services Teamsters Local 665 has celebrated a significant milestone by welcoming a new group of dedicated workers from Bags, a subsidiary of Metropolis Company, based at the bustling San Francisco International Airport (SFO). This achievement underscores the local union's commitment to workforce organization across...
Continue Reading
Thumzup Media Corporation Expands into Dogecoin Investments
Thumzup Media Corporation Expands Its Digital Asset Portfolio Thumzup Media Corporation has made headlines with its strategic decision to venture into the Dogecoin market. This initiative marks the company's inaugural purchase of Dogecoin, acquiring around 7.5 million tokens valued at approximately $2 million, demonstrating confidence in the potential of this...
Continue Reading